Rifaximin 200Mg Tab

DRUG2 trials

Sponsors

University of Michigan, Tata Memorial Centre

Conditions

Acute LeukemiaHuman Gastrointestinal Physiology Data

Phase 1

Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

CompletedNCT05159427

University of MichiganHuman Gastrointestinal Physiology Data

Start: 2022-03-15End: 2026-03-29Updated: 2026-07-20

Phase 2

Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia

RecruitingNCT06058572

Tata Memorial CentreAcute Leukemia

Start: 2024-08-02End: 2027-08-02Target: 166Updated: 2025-07-31